148 related articles for article (PubMed ID: 29325849)
21. Cooked rice prevents hyperlipidemia in hamsters fed a high-fat/cholesterol diet by the regulation of the expression of hepatic genes involved in lipid metabolism.
Choi WH; Gwon SY; Ahn J; Jung CH; Ha TY
Nutr Res; 2013 Jul; 33(7):572-9. PubMed ID: 23827132
[TBL] [Abstract][Full Text] [Related]
22. Alleviation of high-fat diet-induced atherosclerosis and glucose intolerance by a novel GLP-1 fusion protein in ApoE(-/-) mice.
Kong Y; Tong Y; Chen C; Gao M; Gao X; Yao W
Endocrine; 2016 Jul; 53(1):71-80. PubMed ID: 26832342
[TBL] [Abstract][Full Text] [Related]
23. Epiberberine reduces serum cholesterol in diet-induced dyslipidemia Syrian golden hamsters via network pathways involving cholesterol metabolism.
Zou ZY; Hu YR; Ma H; Feng M; Li XG; Ye XL
Eur J Pharmacol; 2016 Mar; 774():1-9. PubMed ID: 26593426
[TBL] [Abstract][Full Text] [Related]
24. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
[TBL] [Abstract][Full Text] [Related]
25. Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters.
Tréguier M; Briand F; Boubacar A; André A; Magot T; Nguyen P; Krempf M; Sulpice T; Ouguerram K
Eur J Clin Invest; 2011 Sep; 41(9):921-8. PubMed ID: 21299553
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice.
Gu W; Lloyd DJ; Chinookswong N; Komorowski R; Sivits G; Graham M; Winters KA; Yan H; Boros LG; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2011 Jul; 338(1):70-81. PubMed ID: 21471191
[TBL] [Abstract][Full Text] [Related]
27. The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice.
Fagman JB; Wilhelmson AS; Motta BM; Pirazzi C; Alexanderson C; De Gendt K; Verhoeven G; Holmäng A; Anesten F; Jansson JO; Levin M; Borén J; Ohlsson C; Krettek A; Romeo S; Tivesten Å
FASEB J; 2015 Apr; 29(4):1540-50. PubMed ID: 25550469
[TBL] [Abstract][Full Text] [Related]
28. Glycyrrhizic acid attenuates the expression of HMG-CoA reductase mRNA in high fructose diet induced dyslipidemic hamsters.
Maurya SK; Srivastava AK
Prague Med Rep; 2011; 112(1):29-37. PubMed ID: 21470496
[TBL] [Abstract][Full Text] [Related]
29. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats.
Sakata S; Ito M; Mera Y; Sasase T; Yamamoto H; Kakutani M; Ohta T
J Diabetes Res; 2014; 2014():803832. PubMed ID: 24895641
[TBL] [Abstract][Full Text] [Related]
30. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.
Trevaskis JL; Griffin PS; Wittmer C; Neuschwander-Tetri BA; Brunt EM; Dolman CS; Erickson MR; Napora J; Parkes DG; Roth JD
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G762-72. PubMed ID: 22268099
[TBL] [Abstract][Full Text] [Related]
31. Conjugated linoleic acid isomers have no effect on atherosclerosis and adverse effects on lipoprotein and liver lipid metabolism in apoE-/- mice fed a high-cholesterol diet.
Cooper MH; Miller JR; Mitchell PL; Currie DL; McLeod RS
Atherosclerosis; 2008 Oct; 200(2):294-302. PubMed ID: 18280484
[TBL] [Abstract][Full Text] [Related]
32. Central Nervous System Regulation of Intestinal Lipoprotein Metabolism by Glucagon-Like Peptide-1 via a Brain-Gut Axis.
Farr S; Baker C; Naples M; Taher J; Iqbal J; Hussain M; Adeli K
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1092-100. PubMed ID: 25675997
[TBL] [Abstract][Full Text] [Related]
33. Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice.
Marangoni A; Fiorino E; Gilardi F; Aldini R; Scotti E; Nardini P; Foschi C; Donati M; Montagnani M; Cevenini M; Franco P; Roda A; Crestani M; Cevenini R
Atherosclerosis; 2015 Aug; 241(2):471-9. PubMed ID: 26086356
[TBL] [Abstract][Full Text] [Related]
34. Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase.
Savransky V; Jun J; Li J; Nanayakkara A; Fonti S; Moser AB; Steele KE; Schweitzer MA; Patil SP; Bhanot S; Schwartz AR; Polotsky VY
Circ Res; 2008 Nov; 103(10):1173-80. PubMed ID: 18832746
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Metabolomic Profiling of Plasma, Urine, and Liver Extracts by
Guo W; Jiang C; Yang L; Li T; Liu X; Jin M; Qu K; Chen H; Jin X; Liu H; Zhu H; Wang Y
J Proteome Res; 2016 Oct; 15(10):3500-3510. PubMed ID: 27570155
[TBL] [Abstract][Full Text] [Related]
36. Glucagon-Like Peptide 2 (GLP-2) Stimulates Postprandial Chylomicron Production and Postabsorptive Release of Intestinal Triglyceride Storage Pools via Induction of Nitric Oxide Signaling in Male Hamsters and Mice.
Hsieh J; Trajcevski KE; Farr SL; Baker CL; Lake EJ; Taher J; Iqbal J; Hussain MM; Adeli K
Endocrinology; 2015 Oct; 156(10):3538-47. PubMed ID: 26132919
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
38. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
39. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
[TBL] [Abstract][Full Text] [Related]
40. Glucagon-like peptide-1 as a key regulator of lipid and lipoprotein metabolism in fasting and postprandial states.
Farr S; Taher J; Adeli K
Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):126-36. PubMed ID: 24801723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
